Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Bone Marrow Transplantation (14)
Leukemia (7)
Scientific Reports (2)
Nature Cancer (2)
British Journal of Cancer (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (23)
Amendments and Corrections (2)
Correspondence (1)
Reviews (1)

Subject Check one or more subjects to show results from those subjects only.

Biological techniques
Biotechnology
Cancer
Diseases
Drug discovery
Gastroenterology
Health care
Medical research
Neuroscience

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–27 of 27 results

Advanced filters: Author: H Hebart Clear advanced filters

Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease

H Krause
H Hebart
H Einsele
Research01 Jun 1997
Bone Marrow Transplantation

Volume: 19, P: 1111-1116
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial

Kim and colleagues perform a phase 2 clinical trial (ELM-2) of odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma and report on the primary analyses of the efficacy and safety profile.

Won Seog Kim
Tae Min Kim
Umar Farooq
ResearchOpen Access17 Mar 2025
Nature Cancer

Volume: 6, P: 528-539
Fatal obstructive lung disease after haploidentical sibling cord blood transplantation

K Ohnuma
Y Toyoda
H Nishihira
Research23 Apr 1998
Bone Marrow Transplantation

Volume: 21, P: 939-941
A network linking scene perception and spatial memory systems in posterior cerebral cortex

Navigation requires integration of visual information with spatial memory representations. Steel et al. describe a new network of brain areas that facilitates the interaction between these perceptual and mnemonic neural systems.

Adam Steel
Madeleine M. Billings
Caroline E. Robertson
ResearchOpen Access11 May 2021
Nature Communications

Volume: 12, P: 1-13
Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis

Stefan Knop
Monika Engelhardt
M. Svaldi
Research28 Aug 2019
Leukemia

Volume: 33, P: 2710-2719
Comparison of cytomegalovirus (CMV) antigenemia and CMV in bronchoalveolar lavage fluid for diagnosis of CMV pulmonary infection after bone marrow transplantation

H Sakamaki
K Yuasa
Y Minamishima
Research01 Jul 1997
Bone Marrow Transplantation

Volume: 20, P: 143-147
Preliminary experience in external quality control of RT-PCR PML-RARα detection in promyelocytic leukemia

P Bolufer
E Barragán
M Briz
Research08 Dec 1998
Leukemia

Volume: 12, P: 2024-2028
Resolution of early cytomegalovirus (CMV) infection after leukocyte transfusion therapy from a CMV seropositive donor

V Witt
G Fritsch
H Gadner
Research13 Aug 1998
Bone Marrow Transplantation

Volume: 22, P: 289-292
Author Correction: Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial

Won Seog Kim
Tae Min Kim
Umar Farooq
Amendments and CorrectionsOpen Access16 Apr 2025
Nature Cancer

Volume: 6, P: 907
The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantation

A Humar
K O’Rourke
T Mazzulli
Research22 Dec 1998
Bone Marrow Transplantation

Volume: 23, P: 45-51
Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) ± folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients

M A Bensmaïne
M Marty
E Cvitkovic
ResearchOpen Access14 Aug 2001
British Journal of Cancer

Volume: 85, P: 509-517
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma

H Einsele
M Bamberg
W I Bensinger
Research03 Sept 2003
Bone Marrow Transplantation

Volume: 32, P: 593-599
Evaluation of the Murex CMV DNA Hybrid Capture assay (version 2.0) for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplant

H Hebart
P Wuchter
H Einsele
Research15 Aug 2001
Bone Marrow Transplantation

Volume: 28, P: 213-218
Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation

H Hebart
T Rudolph
H Einsele
Research22 Aug 2002
Bone Marrow Transplantation

Volume: 30, P: 181-187
Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial

Jochen Gaedcke
Malte Sahrhage
H. Leber
ResearchOpen Access13 Feb 2025
Scientific Reports

Volume: 15, P: 1-12
Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis

R F Schlenk
F Stegelmann
K Döhner
Research24 Oct 2016
Leukemia

Volume: 31, P: 889-895
High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Rüdiger Hehlmann
Astghik Voskanyan
J. Mayer
ResearchOpen Access07 May 2020
Leukemia

Volume: 34, P: 2074-2086
Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

H Einsele
H Hebart
L Kanz
Research27 Mar 2000
Bone Marrow Transplantation

Volume: 25, P: 757-763
Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients

N S Hamza
M A Ghannoum
H M Lazarus
Reviews12 Jul 2004
Bone Marrow Transplantation

Volume: 34, P: 377-389
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT

H Hebart
L Klingspor
H Einsele
Research15 Dec 2008
Bone Marrow Transplantation

Volume: 43, P: 553-561
Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation

C Lengerke
T Ljubicic
H Hebart
Research21 Jun 2006
Bone Marrow Transplantation

Volume: 38, P: 53-60
Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT

H Hebart
C Lengerke
H Einsele
Research28 Jun 2010
Bone Marrow Transplantation

Volume: 46, P: 408-415
A Judgement Bias Test to Assess Affective State and Potential Therapeutics in a Rat Model of Chemotherapy-Induced Mucositis

Rebecca P. George
Timothy H. Barker
Alexandra L. Whittaker
ResearchOpen Access29 May 2018
Scientific Reports

Volume: 8, P: 1-9
OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease

S Knop
H Hebart
H Einsele
Research05 Sept 2005
Bone Marrow Transplantation

Volume: 36, P: 831-837
Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic Leukemia Working Party

S Knop
H Hebart
H Einsele
Correspondence10 May 2007
Leukemia

Volume: 21, P: 1830-1833
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

R Hehlmann
M Lauseker
J Hasford
ResearchOpen Access14 Aug 2017
Leukemia

Volume: 31, P: 2398-2406
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Rüdiger Hehlmann
Astghik Voskanyan
J. Mayer
Amendments and Corrections10 Sept 2020
Leukemia

Volume: 34, P: 2823